PETROVAX PHARM IS A FULL-CYCLE BIOPHARMACEUTICAL COMPANY, A LEADING RUSSIAN DEVELOPER AND MANUFACTURER OF ORIGINAL PHARMACEUTICAL PRODUCTS
The company was founded in 1996 by a team of Russian scientists
25 years of successful experience of operating in the pharma market.
20+ patents for molecules and pharmaceutical manufacturing technologies.
Petrovax Pharm is among the Top-5 immunobiological pharmaceutical manufacturers in Russia.
It has over 800 employees.
Manufacturing capacities allow the annual production of 160 million dosages of immunobiologicals.
The company exports products to 12 countries, including the EAEU, the Middle East and the EU. Petrovax is the largest Russian exporter of medicinal products1.
1 According to RNC Pharma, Pharmaceutical Bulletin, August 25, 2020.
The company's investment strategy is aimed at the investigation, development of production and import substitution of medicines and vaccines used in treatment of socially significant diseases, such as oncological, autoimmune, infectious and orphan diseases.